Title:
TREATMENT OF PULMONARY ARTERY HYPERTENSION WITH DHEA, DHEAS, DHEA ANALOGS OR DHEA DERIVATIVES
Document Type and Number:
WIPO Patent Application WO2005079234
Kind Code:
A3
Abstract:
The present invention is related to the treatment and prevention of pulmonary vascular diseases. Administration of dehydroepiandrosterone (DHEA) has been found to prevent and decrease pulmonary artery hypertension. Accordingly, the invention discloses methods of treating or preventing pulmonary vascular diseases such as pulmonary artery hypertension by pulmonary administration of compositions containing DHEA, DHEAS, DHEA analogs, or DHEA derivatives. Additionally, the DHEA, DHEAS, DHEA analogs, or DHEA derivatives may be used in combination with other pharmaceutical agents, such as bronchodilators, vasodilators, anti-inflammatory agents, and anti-infectious agents to treat pulmonary diseases.
More Like This:
| JP4011114 | Cerebral edema inhibitor |
| WO/2004/089970 | CRYSTALLINE 19-NORSTEROIDS |
| JP2005328771 | HEALTH SUPPLEMENT |
Inventors:
BAULIEU ETIENNE-EMILE (FR)
EXPERTON BETTINA (US)
EXPERTON BETTINA (US)
Application Number:
PCT/US2005/003679
Publication Date:
March 09, 2006
Filing Date:
February 03, 2005
Export Citation:
Assignee:
BAULIEU ETIENNE-EMILE (FR)
EXPERTON BETTINA (US)
EXPERTON BETTINA (US)
International Classes:
(IPC1-7): A61K31/56
Foreign References:
| US6187767B1 | 2001-02-13 |
Other References:
See also references of EP 1722799A4
Download PDF:
Previous Patent: FILMS FOR OPTICAL USE AND METHODS OF MAKING SUCH FILMS
Next Patent: SYSTEM AND METHOD OF CONTROLLING FLUID FLOW
Next Patent: SYSTEM AND METHOD OF CONTROLLING FLUID FLOW